MedPath

SG guided PEC block for chest wall surgeries

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2021/04/033046
Lead Sponsor
GCS MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Elective unilateral modified radical mastectomy for carcinoma breast after obtaining informed consent

Wt 40 to 70 kg

Patients undergoing elective breast reconstruction

Asa 1,2,3

Exclusion Criteria

ASA 4

Male

>70 years of age

Patients who are refusing to give consent

Bilateral breast surgeries

Only lumpectomy

Surgery duration > 4 hours

Carcinoma breast patients with metastasis

Patients allergic to local anaesthetics

Patients with h/o bleeding diathesis

Patients on anticoagulants

Patients with deranged liver function tests

 

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of analgesia <br/ ><br>( time of first rescue analgesia after extubation) <br/ ><br>total cumulative dose of fentanyl (opoid) required for first 24 hours post operatively <br/ ><br>total cumulative dose of PCM (paracetamol ) required for first 24 hours post operativelyTimepoint: Duration of analgesia <br/ ><br>( time of first rescue analgesia after extubation) <br/ ><br>total cumulative dose of fentanyl (opoid) required for first 24 hours post operatively <br/ ><br>total cumulative dose of PCM (paracetamol ) required for first 24 hours post operatively
Secondary Outcome Measures
NameTimeMethod
any adverse effects such as local anaesthesia toxicity, hemodynamic instability, bradycardia, hypotension , nausea or vomitting , parasthesia, respiratory depression. Hematoma, pneumothorax <br/ ><br>Timepoint: During first 24 hours
© Copyright 2025. All Rights Reserved by MedPath